Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Weixuan Zhao & Hongmei Meng. (2022) Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population. Bioengineered 13:3, pages 7709-7745.
Read now
Read now
Isisdoris Rodrigues de Souza, Patrícia Savio de Araujo-Souza & Daniela Morais Leme. (2022) Genetic variants affecting chemical mediated skin immunotoxicity. Journal of Toxicology and Environmental Health, Part B 25:2, pages 43-95.
Read now
Read now
Thaís Teixeira da Silva, Júlia Braga Martins, Maria Do Socorro de Brito Lopes, Pedro Marcos de Almeida, José Luiz Silva Sá & Francielle Alline Martins. (2021) Modulating effect of DL-kavain on the mutagenicity and carcinogenicity induced by doxorubicin in Drosophila melanogaster. Journal of Toxicology and Environmental Health, Part A 84:19, pages 769-782.
Read now
Read now
Jian-Chang Qian, Jian-Ping Cai & Guo-Xin Hu. (2021) Han Chinese specific cytochrome P450 polymorphisms and their impact on the metabolism of anti-hypertensive drugs with adrenoreceptor blocking properties. Expert Opinion on Drug Metabolism & Toxicology 17:6, pages 707-716.
Read now
Read now
Francesco Panza, Madia Lozupone, Eleonora Stella, Lucia Lofano, Carolina Gravina, Maria Urbano, Antonio Daniele, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2016) Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders. Expert Review of Neurotherapeutics 16:12, pages 1357-1369.
Read now
Read now
Kim Vo, Patricia J Neafsey & Carolyn A Lin. (2015) Concurrent use of amphetamine stimulants and antidepressants by undergraduate students. Patient Preference and Adherence 9, pages 161-172.
Read now
Read now
Ingrid Glurich, Amit Acharya, Murray H. Brilliant & Sanjay K. Shukla. (2015) Progress in oral personalized medicine: contribution of ‘omics’. Journal of Oral Microbiology 7:1.
Read now
Read now
Pedro Griman, Yeinmy Moran, Gabriela Valero, Mariana Loreto, Lisbeth Borjas & Miguel A. Chiurillo. (2012) CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: Pharmacogenetics and anthropological implications. Annals of Human Biology 39:2, pages 137-142.
Read now
Read now
Joseph McGraw & Donald Waller. (2012) Cytochrome P450 variations in different ethnic populations. Expert Opinion on Drug Metabolism & Toxicology 8:3, pages 371-382.
Read now
Read now
Bill H. McCarberg. (2011) Chronic Pain: Reducing Costs Through Early Implementation of Adherence Testing and Recognition of Opioid Misuse. Postgraduate Medicine 123:6, pages 132-139.
Read now
Read now
Bill H. McCarberg. (2011) A Critical Assessment of Opioid Treatment Adherence Using Urine Drug Testing in Chronic Pain Management. Postgraduate Medicine 123:6, pages 124-131.
Read now
Read now
Gary Ginsberg, Kathryn Guyton, Douglas Johns, Jennifer Schimek, Kenneth Angle & Babasaheb Sonawane. (2010) Genetic polymorphism in metabolism and host defense enzymes: Implications for human health risk assessment. Critical Reviews in Toxicology 40:7, pages 575-619.
Read now
Read now
Articles from other publishers (66)
Sejung Hwang, Soyoung Lee, Jangsoo Yoon & Jae-Yong Chung. (2023) Population Pharmacokinetic−Pharmacodynamic Modeling of Carvedilol to Evaluate the Effect of Cytochrome P450 2D6 Genotype on the Heart Rate Reduction. Journal of Korean Medical Science 38:22.
Crossref
Crossref
Michael Zastrozhin, Valentin Skryabin, Valeriy Smirnov, Anastasiya Zastrozhina, Elena Grishina, Kristina Ryzhikova, Irina Bure, Pavel Golovinskii, Sergey Koporov, Evgeniy Bryun & Dmitry Sychev. (2022) Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder. American Journal of Therapeutics 29:1, pages e26-e33.
Crossref
Crossref
Debbie M. Figueroa, Ender Karaca, Blake Atwood & Michele Erickson-Johnson. 2022. Clinical Decision Support for Pharmacogenomic Precision Medicine. Clinical Decision Support for Pharmacogenomic Precision Medicine
53
84
.
Michael J. Rieder & Abdelbaset A. Elzagallaai. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
569
593
.
Guiming Hu, Fei Gao, Guanzhe Wang, Yan Fang, Yuanyuan Guo, Jun Zhou, Yuhan Gu, Cunzhen Zhang, Na Gao, Qiang Wen & Hailing Qiao. (2021) Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker. Journal of Translational Medicine 19:1.
Crossref
Crossref
S. R. Gretler, C. J. Finno, P. H. Kass & H. K. Knych. (2021) Functional phenotyping of the CYP2D6 probe drug codeine in the horse. BMC Veterinary Research 17:1.
Crossref
Crossref
Cindy S. Chu, James A. Watson, Aung Pyae Phyo, Htun Htun Win, Widi Yotyingaphiram, Suradet Thinraow, Nay Lin Soe, Aye Aye Aung, Pornpimon Wilaisrisak, Kanokpich Kraft, Mallika Imwong, Warunee Hanpithakpong, Daniel Blessborn, Joel Tarning, Stéphane Proux, Clare Ling, François H. Nosten & Nicholas J. White. (2021) Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria. Antimicrobial Agents and Chemotherapy 65:11.
Crossref
Crossref
Zahraa I. Khamis, Xiaodong Pang, Zihan Cui, Qing-Xiang Amy Sang & Jinfeng Zhang. (2021) Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity. PLOS ONE 16:10, pages e0257072.
Crossref
Crossref
Sheila Annie Peters. 2021. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations
263
292
.
Samir K. Ballas. (2021) Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. Journal of Clinical Medicine 10:3, pages 438.
Crossref
Crossref
Song Gao, Edward C. Bell, Yun Zhang & Dong Liang. (2021) Racial Disparity in Drug Disposition in the Digestive Tract. International Journal of Molecular Sciences 22:3, pages 1038.
Crossref
Crossref
Mikhail S. Zastrozhin, Valentin Y. Skryabin, Alexey E. Petukhov, Ekaterina P. Pankratenko, Elena A. Grishina, Kristina A. Ryzhikova, Marco V. Torrado, Valery V. Shipitsyn, Evgeny A. Bryun & Dmitry A. Sychev. (2021) Impact of CYP2D6 Polymorphism on Equilibrium Concentration of Fluoxetine in Patients Diagnosed With Major Depressive Disorder and Comorbid Alcohol Use Disorders. Journal of Psychiatric Practice 27:5, pages 372-379.
Crossref
Crossref
Gwyneth Zai. 2021. The Neurobiology and Treatment of OCD: Accelerating Progress. The Neurobiology and Treatment of OCD: Accelerating Progress
385
398
.
Allan Giri, Ankita Das, Ajoy K. Sarkar & Ashok K. Giri. (2020) Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19. Genes and Environment 42:1.
Crossref
Crossref
Maria Stella Calafato, Isabelle Austin-Zimmerman, Johan H. Thygesen, Mani Sairam, Antonio Metastasio, Louise Marston, Francisco Abad-Santos, Anjali Bhat, Jasmine Harju-Seppänen, Haritz Irizar, Eirini Zartaloudi & Elvira Bramon. (2020) The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis. The Pharmacogenomics Journal 20:5, pages 629-637.
Crossref
Crossref
Dario Bugada, Luca F. Lorini, Roberto Fumagalli & Massimo Allegri. (2020) Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain. Cancers 12:7, pages 1951.
Crossref
Crossref
Rose H. Manjili, Melika Zarei, Mehran Habibi & Masoud H. Manjili. (2020) COVID-19 as an Acute Inflammatory Disease. The Journal of Immunology 205:1, pages 12-19.
Crossref
Crossref
John T. Wiernikowski & Melanie Brooke Bernhardt. (2020) Review of nutritional status, body composition, and effects of antineoplastic drug disposition. Pediatric Blood & Cancer 67:S3.
Crossref
Crossref
Mikhail Zastrozhin, Valentin Skryabin, Kristina Ryzhikova & Dmitriy Sychev. (2020) Assessment of the impact of the steady state level of microRNA hsa-miR-370-3p concentration on the efficacy and safety profile of fluvoxamine in patients with depressive disorders disorder comorbid with alcohol use disorders. Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery):2, pages 37-46.
Crossref
Crossref
Senthil Packiasabapathy, Michele Hendrickson & Senthilkumar Sadhasivam. 2020. Opioid Therapy in Infants, Children, and Adolescents. Opioid Therapy in Infants, Children, and Adolescents
95
110
.
Scott M. Langevin & Karl T. Kelsey. 2020. Occupational Cancers. Occupational Cancers
21
38
.
Ibidapo S. WilliamsLinda GatchieSandip B. Bharate & Bhabatosh Chaudhuri. (2018)
Biotransformation, Using Recombinant CYP450-Expressing Baker’s Yeast Cells, Identifies a Novel CYP2D6.10
A122V
Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme
. ACS Omega 3:8, pages 8903-8912.
Crossref
Crossref
Efthimios Dardiotis, Vasileios Siokas, Maria Sokratous, Zisis Tsouris, Amalia Michalopoulou, Athina Andravizou, Metaxia Dastamani, Styliani Ralli, Marco Vinceti, Aristidis Tsatsakis & Georgios M. Hadjigeorgiou. (2018) Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants. Environment International 116, pages 122-135.
Crossref
Crossref
Maja Matic, Saskia N de Wildt, Dick Tibboel & Ron H N van Schaik. (2017) Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice. Clinical Chemistry 63:7, pages 1204-1213.
Crossref
Crossref
Ying Su, Yun-yun Zhan, Ben-fu Wang, Si-Cong Wang, Da-peng Dai, Guo-xin Hu, Han Lin, Qing-quan Lian & Jian-ping Cai. (2017)
In vitro
assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone
. Drug Testing and Analysis 9:2, pages 216-220.
Crossref
Crossref
Helen Radford, Pauline Fitzgerald, Stephen Martin & Mark I Johnson. (2016) A service improvement project to review prescribing information provided by general practitioners for new referrals to a UK National Health Service hospital pain clinic: potential implications of CYP2D6 enzyme inhibition. British Journal of Pain 10:4, pages 222-231.
Crossref
Crossref
Carley R. Corado, Daniel S. McKemie & Heather K. Knych. (2016) Dextromethorphan and debrisoquine metabolism and polymorphism of the gene for cytochrome P450 isozyme 2D50 in Thoroughbreds. American Journal of Veterinary Research 77:9, pages 1029-1035.
Crossref
Crossref
Kathryn Z. Guyton & Michael D. Waters. 2016. Toxicogenomics in Predictive Carcinogenicity. Toxicogenomics in Predictive Carcinogenicity
247
279
.
C. R. Corado, D. S. McKemie, A. Young & H. K. Knych. (2016) Evidence for polymorphism in the cytochrome P450 2D50 gene in horses. Journal of Veterinary Pharmacology and Therapeutics 39:3, pages 245-254.
Crossref
Crossref
M. Del Re, V. Citi, S. Crucitta, E. Rofi, F. Belcari, R.H. van Schaik & R. Danesi. (2016) Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?. Pharmacological Research 107, pages 398-406.
Crossref
Crossref
Nikolaos Christidis, Shahin Omrani, Lars Fredriksson, Mattias Gjelset, Sofia Louca, Britt Hedenberg-Magnusson & Malin Ernberg. (2015) Repeated tender point injections of granisetron alleviate chronic myofascial pain - a randomized, controlled, double-blinded trial. The Journal of Headache and Pain 16:1.
Crossref
Crossref
Nelson Varela, Luis A. Quiñones, Jana Stojanova, Joselyn Garay, Dante Cáceres, Silvia Cespedes, Jaime Sasso & Carla Miranda. (2015) Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses. Pharmacological Research 101, pages 124-129.
Crossref
Crossref
Francesco Rua, Sheila J. Sadeghi, Silvia Castrignanò, Francesca Valetti & Gianfranco Gilardi. (2015) Electrochemistry of Canis familiaris cytochrome P450 2D15 with gold nanoparticles: An alternative to animal testing in drug discovery. Bioelectrochemistry 105, pages 110-116.
Crossref
Crossref
Samir K. Ballas. (2015) Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease. European Journal of Haematology 95:2, pages 113-123.
Crossref
Crossref
Da‐Peng Dai, Pei‐Wu Geng, Shuang‐Hu Wang, Jie Cai, Li‐Ming Hu, Jing‐Jing Nie, Ji‐Hong Hu, Guo‐Xin Hu & Jian‐Ping Cai. (2015)
In Vitro
Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population
. Basic & Clinical Pharmacology & Toxicology 117:1, pages 39-43.
Crossref
Crossref
Michael J. Rieder. 2015. Optimizing Treatment for Children in the Developing World. Optimizing Treatment for Children in the Developing World
187
201
.
Scott M. Hynes, Enaksha Wickremsinhe, Wei Zhang, Rodney Decker, Jennifer Ott, Jason Chandler & Malcolm Mitchell. (2015) Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients. Biopharmaceutics & Drug Disposition 36:1, pages 49-63.
Crossref
Crossref
Gwyneth Zai, Eva J Brandl, Daniel J Müller, Margaret A Richter & James L Kennedy. (2014) Pharmacogenetics of antidepressant treatment in obsessive–compulsive disorder: an update and implications for clinicians. Pharmacogenomics 15:8, pages 1147-1157.
Crossref
Crossref
Joseph McGraw. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
323
340
.
Michael Rieder. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
687
707
.
Scott M. Langevin & Karl T. Kelsey. 2014. Occupational Cancers. Occupational Cancers
21
31
.
Thomas B. Gregory. (2013) Hydromorphone: Evolving to Meet the Challenges of Today’s Health Care Environment. Clinical Therapeutics 35:12, pages 2007-2027.
Crossref
Crossref
Jian-Chang Qian, Xin-Min Xu, Guo-Xin Hu, Da-Peng Dai, Ren-Ai Xu, Li-Ming Hu, Fang-Hong Li, Xiu-Hua Zhang, Jie-Fu Yang & Jian-Ping Cai. (2013)
Genetic variations of human
CYP2D6
in the Chinese Han population
. Pharmacogenomics 14:14, pages 1731-1743.
Crossref
Crossref
Yan Xu & Ana Johnson. (2013) Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs. Pain Research and Treatment 2013, pages 1-8.
Crossref
Crossref
Vickie S. Wilson, Nagalakshmi Keshava, Susan Hester, Deborah Segal, Weihsueh Chiu, Chad M. Thompson & Susan Y. Euling. (2013) Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment. Toxicology and Applied Pharmacology 271:3, pages 299-308.
Crossref
Crossref
Weihsueh A. Chiu, Susan Y. Euling, Cheryl Siegel Scott & Ravi P. Subramaniam. (2013) Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era. Toxicology and Applied Pharmacology 271:3, pages 309-323.
Crossref
Crossref
James L KennedyNicholas C Voudouris. (2013) Incorporating psychiatric pharmacogenetics into family practice. Pharmacogenomics 14:10, pages 1121-1124.
Crossref
Crossref
Efthimios Dardiotis, Georgia Xiromerisiou, Christos Hadjichristodoulou, Aristidis M. Tsatsakis, Martin F. Wilks & Georgios M. Hadjigeorgiou. (2013) The interplay between environmental and genetic factors in Parkinson's disease susceptibility: The evidence for pesticides. Toxicology 307, pages 17-23.
Crossref
Crossref
Lauren Zeise, Frederic Y. Bois, Weihsueh A. Chiu, Dale Hattis, Ivan Rusyn & Kathryn Z. Guyton. (2013) Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental Chemicals. Environmental Health Perspectives 121:1, pages 23-31.
Crossref
Crossref
Brandon S Pybus, Jason C Sousa, Xiannu Jin, James A Ferguson, Robert E Christian, Rebecca Barnhart, Chau Vuong, Richard J Sciotti, Gregory A Reichard, Michael P Kozar, Larry A Walker, Colin Ohrt & Victor Melendez. (2012) CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malaria Journal 11:1.
Crossref
Crossref
Alexander V. LyubimovPeter L. Bullock & Olga V. Trubetskoy. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
26
.
A. Serin, H. Canan, B. Alper & M. Gulmen.. (2012) The frequencies of mutated alleles of CYP2D6 gene in a Turkish population. Forensic Science International 222:1-3, pages 332-334.
Crossref
Crossref
Zhijun Wang, Benjamin Lee, Daniel Pearce, Shuai Qian, Yanfeng Wang, Qizhi Zhang & Moses S. S. Chow. (2013) Meclizine Metabolism and Pharmacokinetics: Formulation on Its Absorption. The Journal of Clinical Pharmacology 52:9, pages 1343-1349.
Crossref
Crossref
Alexander V. LyubimovBill Gurley, Kim E. Fifer & Zöe Gardner. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
79
.
Carlo L. Bello, Robert R. LaBadie, Grace Ni, Tanya Boutros, Carol McCormick & M. Noella Ndongo. (2011) The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers. Cancer Chemotherapy and Pharmacology 69:4, pages 991-997.
Crossref
Crossref
Mark Walzer, Ihor Bekersky, Robert A. Blum & Dwain Tolbert. (2012) Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:4, pages 340-353.
Crossref
Crossref
Leah A. Gates, Ding Lu & Lisa A. Peterson. (2012)
Trapping of
cis
-2-Butene-1,4-dial to Measure Furan Metabolism in Human Liver Microsomes by Cytochrome P450 Enzymes
. Drug Metabolism and Disposition 40:3, pages 596-601.
Crossref
Crossref
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
161
181
.
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
383
399
.
Koji Chiba, Motohiro Kato, Takashi Ito, Toshio Suwa & Yuichi Sugiyama. (2012) Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes. Drug Metabolism and Pharmacokinetics 27:4, pages 405-413.
Crossref
Crossref
Cristian Palmiere, Maria del Mar Lesta, Sara Sabatasso, Patrice Mangin, Marc Augsburger & Frank Sporkert. (2012) Usefulness of postmortem biochemistry in forensic pathology: Illustrative case reports. Legal Medicine 14:1, pages 27-35.
Crossref
Crossref
V.B. Urlacher. 2012. Comprehensive Chirality. Comprehensive Chirality
275
294
.
Laura N. RiccardiRossana LanzellottoDonata LuiselliStefania CeccardiMirella FalconiCarla BiniSusi Pelotti. (2011)
CYP2D6
Genotyping in Natives and Immigrants from the Emilia-Romagna Region (Italy)
. Genetic Testing and Molecular Biomarkers 15:11, pages 801-806.
Crossref
Crossref
Arjun Muralidharan & Maree T Smith. (2011) Pain, analgesia and genetics. Journal of Pharmacy and Pharmacology 63:11, pages 1387-1400.
Crossref
Crossref
Samuel L. C. Moors, Ann M. Vos, Maxwell D. Cummings, Herman Van Vlijmen & Arnout Ceulemans. (2011) Structure-Based Site of Metabolism Prediction for Cytochrome P450 2D6. Journal of Medicinal Chemistry 54:17, pages 6098-6105.
Crossref
Crossref
Anthony Rowe, Lillian Yuan Zhang & Iqbal Ramzan. (2011) Toxicokinetics of Kava. Advances in Pharmacological Sciences 2011, pages 1-6.
Crossref
Crossref